Cognitive impairment is more common and severe in older adults with MS than in younger patients, but this is driven by ...

Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis, researchers reported in the New England Journal ...

Among nearly 600 patients with multiple sclerosis, there were lower odds of disability and progression among people diagnosed and treated within six months of symptoms onset. Photo by stevepb/Pixabay ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to manage symptoms ...

Racial and ethnic differences in the severity, prognosis, and mortality of multiple sclerosis (MS) have been the focus of intensifying research over the last decade, and emerging evidence suggests ...

A major Murdoch University review has found that for many people with multiple sclerosis (MS), walking is hindered not only ...

Share on Pinterest Researchers say brain lesions don’t appear to be connected to severe disability in multiple sclerosis. SeventyFour/Getty Images About 1 million people in the United States live with ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving smoldering inflammation and neurodegeneration that drives disability in ...

Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...

NEW YORK (Reuters Health) - The abnormal immune response that leads to multiple sclerosis, or MS, is stronger in African Americans than in whites with the disease, new research indicates. This may ...

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...